Insulin

Guildford Peptide Hormones

Insulin-like Growth Factor 1

Guildford Peptide Hormones

Insulin-like Growth Factor Binding Protein-3

Guildford Peptide Hormones

Interferon Gamma Release Assays (Mycobacterium tuberculosis) IGRA TB

Immunology, Immunochemistry & Allergy (IIA)

Autoimmunity EQA scheme

Interleukin-6 (IL-6) (Pilot)

Immunology, Immunochemistry & Allergy (IIA)

Interpretative Comments in Clinical Chemistry

Clinical Chemistry (Birmingham Quality)

Interpretative: HFE Genotype and Hereditary Haemochromatosis (Scheme 5B)

Histocompatibility & Immunogenetics

To assess participants' ability to make an accurate, clear and concise clinical report, appropriate for the range of clinical staff involved in a patient's care and treatment, given HFE genotype and other relevant clinical information.

Interpretive HLA Genotype (Scheme 4A1i)

Histocompatibility & Immunogenetics

To assess participants' ability to correctly interpret their Scheme 4A1 DNA based typing results to the 'split' HLA specificity level. Note that Scheme 4A1i is only available to participants registered for Scheme 4A1.

Intrinsic Factor Antibodies

Clinical Chemistry (Birmingham Quality)

Assessment of analytical bias and its consistency across time

ISCN Accuracy (Pilot)

Genomics (GenQA)

Using ISCN to describe cytogenomic results

JAK2 p.Val617Phe (V617F) Mutation Status

Leucocyte Immunophenotyping

KIR Genotyping (Scheme 9)

Histocompatibility & Immunogenetics

To assess participants' ability to correctly determine the presence or absence of specific KIR genes

KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease

Leucocyte Immunophenotyping

Lead, Cadmium, Manganese, Arsenic, Magnesium, Mercury, Zinc, Selenium, Thallium, Chromium and Cobalt in Blood

Trace Elements

Leukaemia Diagnostic Interpretation (Part 2)

Leucocyte Immunophenotyping

This programme is designed to assess a laboratory's ability to diagnose leukaemia using a full spectrum of laboratory tests.